Page last updated: 2024-08-24

valsartan and cilostazol

valsartan has been researched along with cilostazol in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Burgin, K; Daiber, A; Daub, S; Gori, T; Hausding, M; Knorr, M; Kröller-Schön, S; Münzel, T; Oelze, M; Rümmler, R; Sartor, D; Scherhag, A; Schreiner, J; Schuff, A; Schulz, E; Wenzel, P1
Burgin, K; Daiber, A; Gori, T; Jansen, T; Knorr, M; Kopp, M; Kröller-Schön, S; Münzel, T; Oelze, M; Sartor, D; Scherhag, A; Schulz, E; Stamm, P; Tran, LP; Ullmann, E; Welschof, P1

Reviews

1 review(s) available for valsartan and cilostazol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for valsartan and cilostazol

ArticleYear
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Characterization of new organic nitrate hybrid drugs covalently bound to valsartan and cilostazol.
    Pharmacology, 2012, Volume: 90, Issue:3-4

    Topics: Animals; Cilostazol; Male; Nitrates; Oxidative Stress; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Tetrazoles; Valine; Valsartan; Vasoconstriction; Vasodilator Agents

2012
Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and Valsartan.
    Pharmacology, 2018, Volume: 101, Issue:1-2

    Topics: Animals; Aorta; Cilostazol; Drug Combinations; Drug Synergism; Male; Metoprolol; Mitochondria, Heart; Nitrates; Oxidative Stress; Rats, Wistar; Tetrazoles; Valsartan; Vasodilator Agents

2018